These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32356916)

  • 1. CD34 positive tubular basement membrane in testicular germ cell tumours: a potential staging pitfall.
    Gohlke AL; Amin MB; Smith SC
    Histopathology; 2020 Aug; 77(2):331-333. PubMed ID: 32356916
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of CD34 antigen in testicular mixed germ cell tumor.
    Hamazaki S; Okada S
    Pathol Int; 2003 Dec; 53(12):853-7. PubMed ID: 14629751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
    Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
    Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
    [No Abstract]   [Full Text] [Related]  

  • 4. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
    Bu L; Yang Q; McMahon L; Xiao GQ; Li F
    Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and staging of germ-cell tumours of the testis].
    Mottet N; Berger N; Droz JP
    Rev Prat; 2007 Feb; 57(4):365-78. PubMed ID: 17455738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biomarkers in testicular germ cell tumors: updates of 2020.
    Sarkis J; R Kourie H; Alkassis M; Samaha R; Sarkis P
    Biomark Med; 2021 Feb; 15(2):83-86. PubMed ID: 33442992
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: the continued value of central histopathological review of testicular tumours.
    Swaro R; Deshmukh N; Chaudhri S
    Histopathology; 2007 Mar; 50(4):529-30. PubMed ID: 17448038
    [No Abstract]   [Full Text] [Related]  

  • 8. NCCN clinical practice guidelines in oncology: testicular cancer.
    Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
    J Natl Compr Canc Netw; 2009 Jun; 7(6):672-93. PubMed ID: 19555582
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of the C-terminal region of the SSX protein is a useful diagnostic biomarker for spermatocytic tumour.
    Anderson WJ; Maclean FM; Acosta AM; Hirsch MS
    Histopathology; 2021 Nov; 79(5):700-707. PubMed ID: 33963590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metachronous testicular seminoma with an interval of 14 years from the first nonseminomatous testicular tumor: a case report].
    Kawasaki M; Satoh Y; Nakashima K; Nishimura K; Kaneko A; Udoh K; Fujiyama C; Uozumi J
    Nihon Hinyokika Gakkai Zasshi; 2009 Jan; 100(1):16-21. PubMed ID: 19198225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of urological malignancy: the testes.
    Wilkins M; Horwich A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT4: a sensitive and specific immunohistochemical marker for metastatic germ cell tumors.
    Lau SK; Chang KL
    Adv Anat Pathol; 2006 Mar; 13(2):76-9. PubMed ID: 16670461
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma].
    Liu DL; Lu YP; Shi HY; Zhu SX; Lü JW; Li WF; Rong X
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):38-41. PubMed ID: 18297810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34.
    Ricci C; Franceschini T; Giunchi F; Borsato M; Mollica V; Massari F; Fiorentino M
    Pathol Res Pract; 2021 Nov; 227():153637. PubMed ID: 34619577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of testicular cancer].
    Schneevoigt B; Stief CG; Karl A
    MMW Fortschr Med; 2013 Dec; 155(21-22):40-2. PubMed ID: 24724271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and therapy of testicular tumors].
    Albers P
    Urologe A; 2002 Jul; 41(4):374-85; quiz 386-7. PubMed ID: 12214458
    [No Abstract]   [Full Text] [Related]  

  • 18. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-KIT protein expression does not discriminate neoplastic from non-neoplastic intratubular germ cells.
    Biermann K; Stoop H; Looijenga L
    Histopathology; 2012 May; 60(6):1017-9. PubMed ID: 22340755
    [No Abstract]   [Full Text] [Related]  

  • 20. Testicular tumors--some new and a few perennial problems.
    Young RH
    Arch Pathol Lab Med; 2008 Apr; 132(4):548-64. PubMed ID: 18384207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.